1The role of therapeutic cancer vaccines in the modern immunotherapy era: State of the art with recent progress and future challenges.2026 · Europe PMC
2Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.2026 · Europe PMC
3Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients.2026 · Europe PMC
4A Comparative Study of Melanocytic Tumours: Linking Portuguese Dogs and Cats to Human Cases.2026 · Europe PMC
5Same mutation, different fates: The Yin-Yang of BRAF-driven therapeutic responses in melanoma and colorectal cancer.2026 · Europe PMC
6Contemporary insights into head and neck cancers: Epidemiology, molecular biology, diagnosis, and therapeutic advances.2026 · Europe PMC
7Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery.2026 · Europe PMC
8Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.2026 · Europe PMC
9Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.2026 · Europe PMC
10Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.2026 · Europe PMC
11Is the incidence of early-onset cancers increasing in the northeast of Italy? A 30-year analysis of the regional cancer registration data by age, 1987-2019.2026 · Europe PMC
13Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors.2026 · Europe PMC
15Does Indocyanine Green define margins in Wilms tumour? A novel macroscopic and microscopic ex-vivo study.2026 · Europe PMC
16Low-grade glial neoplasms of germ cell origin may represent maturation of embryonic-type neuroectodermal elements.2026 · Europe PMC
17A Novel Deleterious Variant and a Founder Effect in Four New Families of MBD4-Associated Neoplasia Syndrome Recruited Over a Period of 20 Years.2026 · Europe PMC
18Disease-phase-specific resource utilization and healthcare costs in metastatic colorectal cancer: a subgroup analysis of the Finnish RAXO study.2026 · Europe PMC
19Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief Report.2026 · Europe PMC
20Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.2026 · Europe PMC
22Association between tumor laterality and prognosis across different ovarian cancer subtypes: Results from SEER database and a Chinese multicenter cohort.2026 · Europe PMC
23eIF3i facilitates NELFCD translation to promote metastasis via regulating EMT and invadopodia.2026 · Europe PMC
24Renal epithelioid angiomyolipoma: A multi-institutional, international cohort study with emphasis on clinicopathologic prognostic indicators.2026 · Europe PMC
25Advancements in breast cancer mRNA vaccines: Current development and future prospects.2026 · Europe PMC
26Recent advances in detection techniques regarding predictive, prognostic and diagnostic biomarkers in body fluids and its future challenges.2026 · Europe PMC
27Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case series.2026 · Europe PMC
28Validation of a prognostic calculator to predict recurrence and mortality in melanoma patients undergoing sentinel lymph node biopsy.2026 · Europe PMC
29LDH-driven lactic acidosis in hypoxic solid tumors: Mechanisms of metastatic transformation and therapeutic opportunities.2026 · Europe PMC
30Prognostic and immunological significance of tryptophan metabolic enzymes across endometrial cancer molecular subtypes.2026 · Europe PMC
31Setup and target volume shape variation in rectal cancer radiotherapy: a systematic literature review.2026 · Europe PMC
34Number of Examined Lymph Nodes in the Highest Quartile Enhances Staging and Prognosis for Patients with Esophageal Cancer Receiving Neoadjuvant Therapy.2026 · Europe PMC
35Application of a preclinical 18-gene classifier to patients with locally advanced HNSCC.2026 · Europe PMC
36Clinicopathological and prognostic significance of mucin signatures in lower gastrointestinal cancer-a systematic review and meta-analysis.2026 · Europe PMC
38Impact of pneumatic tube system transport and blood collection tubes on cell-free DNA analysis of plasma samples.2026 · Europe PMC
39Population-Based Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer.2026 · Europe PMC
41Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology group.2026 · Europe PMC
42Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19).2026 · Europe PMC
43Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register.2026 · Europe PMC
44Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.2026 · Europe PMC
45LYnet: Computational identification of tumor T cell antigens using convolutional and recurrent neural networks.2026 · Europe PMC
46Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis.2026 · Europe PMC
47Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma.2026 · Europe PMC
48Discovery of a fluorinated squaramide as a potential CXCR2- autophagy signalling modulator in chemo-resistant oral squamous cell carcinoma and polyploid giant cancer cells.2026 · Europe PMC
49Bilateral carcinoid heart disease without intracardiac shunt in a patient with advanced functional small bowel neuroendocrine tumour: a clinical conundrum.2026 · Europe PMC
51Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.2026 · Europe PMC
53Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.2026 · Europe PMC
54Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.2026 · Europe PMC
56Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial.2026 · Europe PMC
57Assessing Predictive Factors for Poor Survival Outcomes With Tumour Sidedness in Early-Stage Colon and Rectal Cancers.2026 · Europe PMC
58Evaluation of dosimetric and radiobiological parameters (TCP/NTCP) based on daily CBCT in lung cancer patients.2026 · Europe PMC
59High prevalence of <i>KRAS</i> and <i>GNAS</i> mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.2026 · Europe PMC
60Analysis of perioperative mortality in 66 patients with head and neck cancer: A retrospective study.2026 · Europe PMC